Dr. Melanie Franklin is a pediatric psychologist at Children's Hospital of Philadelphia with expertise in sleep disorders, treatment adherence, and pediatric psychology. She operates within the Department of Child and Adolescent Psychiatry and Behavioral Sciences and collaborates across multiple teams. BA in Psychology – Muhlenberg College PhD in School Psychology – Lehigh University Residency and Fellowship in Pediatric Psychology – Nemours/A.I. DuPont Children’s Hospital Her research focuses on: Sleep behavior in chronic illness populations Mental health communication barriers ADHD functional outcomes Treatment adherence strategies Recent publications demonstrate expertise in ADHD comorbidities , Cystic Fibrosis sleep interventions , and academic functioning analysis . Key collaborations include: Psychiatry and Behavioral Sciences Sleep Center Pulmonary and Sleep Medicine Division
Professor Jennifer Whitty is an applied health economist at the University of East Anglia , affiliated with the Norwich Medical School and the Centre of Research Excellence in Telehealth . Her research bridges health economics, patient preferences, and health policy, with a focus on quality of life valuation and economic evaluation. Education: Doctor of Philosophy (Griffith University, 2008), Graduate Diploma in Clinical Pharmacy (University of Queensland, 2002), Bachelor of Pharmacy (University of Wales, 1992) Her work emphasizes person-centered methodologies , particularly discrete choice experiments, to evaluate patient and public preferences for healthcare delivery and outcomes. Key research areas include: Treatment burden and quality of life in chronic diseases like cystic fibrosis Economic evaluation of pharmaceuticals and health technologies Asset-based approaches to community health Priority-setting frameworks in health policy Prof. Whitty has secured over AU$27 million in research funding from organizations including the NHMRC and National Institute for Health and Care Research , and serves on editorial boards for Medical Decision Making and Applied Health Economics and Health Policy .
Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
Jennifer A. Smith, PhD, MPH is an Associate Professor of Epidemiology and Research Associate Professor of Survey Research at the University of Michigan School of Public Health . She also serves as Director of the Certificate in Public Health Genetics and is Assistant Director of the Cohort Development working group for U-M Precision Health and the Michigan Genomics Initiative. Education: PhD, Epidemiology, University of Michigan (2011) MA, Statistics, University of Michigan (2009) MPH, Health Management and Policy, University of Michigan (2005) BS, Biological Sciences, Cornell University (2001) Research Interests: Dr. Smith is a genetic epidemiologist whose work lies at the intersection of genomics, epigenomics, and social epidemiology . She investigates how genetic, epigenetic, and transcriptomic variation influence age-related chronic diseases such as cardiovascular disease, hypertension, dementia, and cognitive decline. A major focus is understanding how social, psychosocial, and neighborhood determinants interact with genetic risk to shape socioeconomic and racial/ethnic health disparities . Research Projects: Her work leverages large, multi-ethnic cohorts including the Health and Retirement Study (HRS), GENOA, SWAN, MESA, and LASI. She is a core faculty member of the Center for Social Epidemiology and Population Health (CSEPH) , and affiliated with MiCDA, the Center for Midlife Science, and the PNG Program . She also collaborates with leading consortia such as CHARGE and TOPMed. Selected Trends in Publications: Her recent work (2022–2025) emphasizes epigenetic mediation of social determinants on cardiovascular and cognitive health, polygenic risk scores across diverse ancestries , and multi-omics integration in aging and disease. These studies consistently highlight how social environments and genetic architecture jointly influence health outcomes across populations. Contact: Email: smjenn@umich.edu Office: 734-615-9455 Address: 2631 SPH I, 1415 Washington Heights, Ann Arbor, MI 48109
Melody Alsaker is an Associate Professor in the Department of Mathematics at Gonzaga University, where she has held this position since January 2016. Her research focuses on medical imaging and applied inverse problems, particularly in the field of electrical impedance tomography (EIT). She specializes in mathematical modeling, algorithm design, and biomedical image processing, with applications in pulmonary and thoracic imaging. Her work emphasizes improving EIT reconstruction techniques using the D-bar method, incorporating spatial priors, and developing real-time solutions for clinical applications. Notable contributions include the ACE1 EIT system for thoracic imaging and studies on stroke classification, air trapping in lungs, and surrogate measures of pulmonary function in children with cystic fibrosis. Alsaker's research bridges mathematics and engineering, addressing challenges in medical imaging accuracy and computational efficiency. Her collaborations span disciplines, including biomedical engineering, respiratory physiology, and clinical medicine.
Professor Robert McLaughlin is a faculty member in the School of Biomedicine at the University of Adelaide, affiliated with the Faculty of Health and Medical Sciences. He leads the Bioengineering Imaging Group and serves as Managing Director of the start-up Miniprobes. His research focuses on developing optical imaging technologies, including non-invasive tools for blood flow assessment and miniaturized imaging probes. He has secured over $14M in research grants and holds an h-index of 45 with 98 journal papers, 7 patents, and 2 book chapters. Prof. McLaughlin’s career includes roles at the University of Oxford and Siemens Medical Solutions, followed by academic leadership since 2007. His innovations span optical coherence tomography (OCT), fluorescence imaging, and dual-modality systems for clinical applications. Awards include the 2014 WA Innovator of the Year, 2015 Australian Innovation Challenge, and 2016 South Australian Premier’s Research Fellowship. His research emphasizes practical medical solutions, such as imaging needles for deep-tissue diagnostics and optical devices for real-time surgical monitoring. The Bioengineering Imaging Group collaborates with industry and academia to translate technologies into clinical practice.
Carmen Bergom, MD, PhD, is an Associate Professor of Radiation Oncology at Washington University School of Medicine (WashU Medicine), where she joined the faculty in 2020. She holds secondary appointments in the Division of Cancer Biology and the Siteman Cancer Center. Her research focuses on leveraging genetic models to improve radiation therapy efficacy while mitigating radiation-induced cardiotoxicity , particularly in breast cancer patients. Key areas include radiation biology , tumor microenvironment , and cardio-oncology . Recent publications highlight her work in genetic mapping of radiation sensitivity (e.g., rat chromosome 3 variants), innovative imaging techniques (e.g., integrin-targeted PET), and clinical trial design for cardiovascular risk stratification. Her laboratory has pioneered the first genetic studies of radiation-induced cardiac dysfunction. Scientific awards include the Michael Fry Research Award (2021) and recognition as a Top Doctor in America (2018, 2019). She serves as Chair of the ASTRO Science Council Scientific Review Panel and co-chair of the Clinical and Experimental Research in Radiation Oncology meeting at ESTRO. Dr. Bergom treats breast cancer patients clinically and mentors students across all levels (undergraduate to postdoctoral). Her work bridges basic research with clinical applications , aiming to develop biomarkers and therapeutic targets for radiation oncology.
Houman Savoji is an Associate Professor in the Department of Pharmacology and Physiology at the Faculty of Medicine, University of Montreal. He is also a full-time researcher at the CHU Sainte-Justine Research Center and principal investigator in regenerative medicine, organs-on-chip, and bioprinting at TransMedTech Institute. Dr. Savoji received his PhD in Biomedical Engineering from the Institute of Biomedical Engineering at Polytechnique Montréal in 2016. He then completed a postdoctoral fellowship at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. His research expertise combines advanced manufacturing technologies (micro- and nano-fabrication, 3D bioprinting, microfluidics, cell electrospinning) with functional and composite materials for applications in tissue engineering, regenerative medicine, and organs-on-chip. His work focuses on the design, development, optimization, implementation, and characterization of innovative functional biomaterials using emerging engineering technologies, with particular emphasis on cardiac tissue engineering and biomimetic pulmonary heart valves for pediatric patients. Dr. Savoji has published extensively on biomaterials, tissue engineering, 3D bioprinting, and organ-on-chip technologies. His recent publications demonstrate expertise in viscoelastic characterization of soft tissues, engineering immune responses to biomaterials, ceramic engineering for biomedical applications, and advanced 3D bioprinting techniques for cardiac and vascular tissue engineering. 2017-2020, Postdoctoral Research Grant, CIHR 2017-2019, Postdoctoral Research Grant, FRQNT 2017-2018, Human Society of International Grant, Human Toxicity Assessment Project 2016, CR-CHUM Research Center Award 2015, Star Student-Researcher Award, FRQNT 2014-2015, Jane and Frank Warchol Fellowship, Society of Vacuum Coaters Foundation 2013, Institute of Textile Science Award 2012-2015, Excellence Doctoral Scholarship for Foreign Students, FRQNT Dr. Savoji has supervised Master's students including Ines Barrakad (2024) working on 'Advanced manufacturing technologies versus molding of corneal implants: 3D printing vs molding of a Keratoprosthesis' and Zineb Ajji (2023) researching 'Development of perfusable patches by 3D bioprinting for potential application in cardiac tissue regeneration.' He has secured numerous research grants from organizations including CIHR, NSERC, FRQNT, FRQS, MITACS, and others for projects related to 3D bioprinting of cardiac tissues, biomimetic heart valves, and other tissue engineering applications. The Savoji Laboratory, located within the Department of Pharmacology and Physiology and Institute of Biomedical Engineering of the Faculty of Medicine of the University of Montreal, the Research Center of the CHU Sainte-Justine (CHUSJ), and the TransMedTech Institute, focuses on multidisciplinary research involving 3D bioprinting using stem-cell derived human cardiac cells to fabricate functional cardiac tissues for transplantation and drug discovery applications.
Dr. Timothy Hresko is a Professor of Orthopedic Surgery at Harvard Medical School and serves as an Orthopedic Surgeon in the Orthopedics and Sports Medicine Department at Boston Children's Hospital. He also holds the position of Director of Spine Research and Quality Improvement in the Department of Orthopedic Surgery. Dr. Hresko received his medical degree from Columbia University, College of Physicians and Surgeons in 1981. He completed his internship at New England Deaconess Hospital in 1982, followed by residency at New England Medical Center in 1987, and a fellowship at Boston Children's Hospital in 1988. He is certified by the American Board of Orthopedic Surgery. His research focuses on orthopedic surgery, particularly spine surgery and pediatric orthopedics. Dr. Hresko's work centers on scoliosis treatment, spinal deformity correction, and outcomes of pediatric spinal fusion surgeries. He has conducted extensive research on surface topography measurements for scoliosis assessment, bracing techniques for adolescent idiopathic scoliosis, and surgical outcomes for various spinal conditions. His recent work explores the biomechanical effects of thoracolumbosacral orthosis design and the relationship between spinal deformity and patient self-image. Dr. Hresko's recent publications demonstrate a strong emphasis on technological advancements in spine surgery, including robotic pedicle screw placement and computer vision algorithms. His work also explores the relationship between socioeconomic factors and surgical outcomes, as well as innovative approaches to non-surgical management of scoliosis. Scoliosis Research Society (SRS) Pediatric Orthopaedic Society of North America (POSNA) American Academy of Orthopaedic Surgeons (AAOS) American Board of Orthopaedic Surgery As Director of Spine Research and Quality Improvement, Dr. Hresko leads initiatives to enhance patient outcomes and optimize care pathways for children with spinal conditions. His work emphasizes evidence-based approaches to pediatric spine care, with particular attention to quality improvement and research translation into clinical practice.
Professor Shaun Gregory is the Director of the Centre for Biomedical Technologies at Queensland University of Technology (QUT), where he also serves as Co-Director of the Artificial Heart Frontiers Program, Founder and Director of the Heart Hackathon student team competition, and Director of the CardioRespiratory Engineering and Technology Laboratory. He holds appointments in the Faculty of Engineering, School of Mechanical, Medical & Process Engineering. His educational background includes Bachelor, Masters (research), and PhD degrees, all awarded by QUT. He also holds both NHMRC and Heart Foundation fellowships, demonstrating his significant contributions to cardiovascular research. Professor Gregory's research applies a translational approach to cardiovascular engineering with a particular focus on devices used to support or replace the heart. His work brings together multidisciplinary teams of engineering, biomedical science, design, and medicine to develop novel technical solutions for clinically relevant problems. His research has changed clinical practice on numerous occasions and assisted with the regulatory approval of medical devices. His areas of interest include mechanical circulatory support, artificial heart development, cardiovascular device engineering, and hemodynamics. His publication portfolio demonstrates a strong focus on extracorporeal membrane oxygenation (ECMO), ventricular assist devices, and cardiovascular device testing. His recent work has explored computational fluid dynamics in blood flow analysis, novel cannula design for circulatory support, and the hemodynamic effects of various cardiovascular devices. His research often bridges engineering principles with clinical applications, resulting in practical innovations in cardiac support technologies. NHMRC Fellowship Heart Foundation Fellowship President-Elect of the International Society for Mechanical Circulatory Support Professor Gregory has successfully secured more than $65 million in research funding and has published over 100 research articles in his field. He is actively involved in mentoring the next generation of researchers, currently accepting Honours, Masters, and PhD students. His CardioRespiratory Engineering and Technology Laboratory serves as a hub for interdisciplinary research that brings together engineering, biomedical science, and clinical expertise to address critical challenges in cardiovascular medicine.
Dr. Bill Sheel is a Professor and Distinguished University Scholar at the School of Kinesiology, University of British Columbia. His research focuses on the integrative physiology of exercise, particularly respiratory and cardiovascular interactions. Email: bill.sheel@ubc.ca Office: Chan Gunn Pavilion, Room 221B, Vancouver, BC Lab: Health and Integrative Physiology Laboratory Research Interests: Dr. Sheel investigates respiratory physiology during exercise, cardiovascular modulation by breathing patterns, and human performance optimization. His work spans elite athletes, aging populations, and clinical applications. Publication Trends: Recent studies include pulmonary mechanics in exercise physiology, respiratory muscle training applications, and socio-cultural factors in sports science. Collaborative works address aging interventions and environmental influences on athletic performance. Scientific Recognition: Distinguished University Scholar, UBC Laboratory & Collaborations: Leads the Health and Integrative Physiology Laboratory at UBC, focusing on respiratory-cardiovascular integration and exercise tolerance mechanisms.
Vitaly Kheyfets, PhD, serves as Associate Professor in the Department of Pediatrics-Critical Care Medicine at the University of Colorado Anschutz Medical Campus School of Medicine, where he directs research at the intersection of pediatric critical care and cardiopulmonary pathophysiology with emphasis on pulmonary arterial hypertension (PAH). His primary research focuses on right ventricular adaptation to pulmonary hypertension, utilizing machine learning-driven multi-omics analysis to identify disease biomarkers and molecular networks. He pioneers computational fluid dynamics approaches for hemodynamic modeling in congenital heart conditions like Glenn physiology, while also investigating sleep oscillatory patterns as neurodegenerative biomarkers. His methodology integrates proteomics, spatial transcriptomics, and pressure waveform analysis to dissect vascular remodeling mechanisms. Publication trends reveal a strong emphasis on translating computational models into clinical applications for PAH prognostication, with recent work developing AI-cooperative diagnostic platforms and characterizing microvascular changes in the right ventricle. Cross-disciplinary collaborations span proteomics, imaging, and sleep neuroscience, demonstrating consistent innovation in both pulmonary hypertension and neurodegenerative disease biomarker discovery.
Montserrat Anguera, Ph.D. is an Associate Professor in the Department of Biomedical Sciences at the University of Pennsylvania's School of Veterinary Medicine. Her research focuses on epigenetic mechanisms of gene regulation underlying sex differences in development and disease, with particular emphasis on X-chromosome inactivation (XCI) and its implications for female-biased autoimmune disorders. Dr. Anguera investigates how gene expression from the X-chromosome is regulated to ensure dosage compensation between males and females, and how these mechanisms become altered in diseases exhibiting sex-bias. Her laboratory has established novel epigenetic pathways involving the X-chromosome that impact human development, immune responses, and lymphocyte function. She employs advanced techniques including RNA/DNA fluorescence in situ hybridization, immunofluorescence, and allele-specific RNA sequencing to achieve single-cell resolution of epigenetic characteristics of the inactive X chromosome. Her research reveals a consistent focus on the intersection of X-chromosome biology and immunology, particularly regarding sex-biased autoimmune diseases like systemic lupus erythematosus. Key findings include the discovery that lymphocytes maintain X-chromosome inactivation differently than other somatic cells, with the inactive X exhibiting euchromatic features in female lymphocytes that may underlie female bias in autoimmune disorders. She coined the term 'dynamic XCI maintenance' to describe how T and B cells relocalize Xist RNA and heterochromatic marks to the inactive X chromosome following antigen-mediated stimulation. Dr. Anguera's laboratory includes postdocs Katherine Forsyth and Nikhil Jiwrajka, research specialist Zowie Searcy, graduate students Isabel Sierra and Natalie Toothacre, postdoctoral researcher Nuriban Valero-Pacheco, and PhD student Emma Welter. Together, they investigate epigenetic regulation of X-linked genes in development and disease contexts. She is an active member of multiple prestigious research institutes at Penn, including the Epigenetics Institute, Institute for Immunology, Center for Research on Reproduction & Women's Health, and Institute for Regenerative Medicine. Her work bridges epigenetics, immunology, and developmental biology, providing novel insights into mechanisms underlying female-biased autoimmune disorders.
Marita Dale is a Senior Lecturer in the Discipline of Physiotherapy at the University of Sydney and an Early Career Researcher affiliated with the Charles Perkins Centre. She specializes in cardiorespiratory physiotherapy, focusing on exercise interventions for chronic respiratory and cardiac diseases, particularly asbestos-related and dust-related conditions. Her work emphasizes improving accessibility to pulmonary rehabilitation services and leveraging mHealth technologies for patient care. Education: PhD in Physiotherapy (2016, University of Sydney). Her research interests include optimizing pulmonary rehabilitation through mobile health platforms, such as the m-PR™ app, and investigating pediatric burn injury rehabilitation, including orthosis use and scar prevention. She also explores multimorbidity management and simulation-based learning in healthcare education. Recent studies have highlighted her contributions to COPD care protocols, telehealth implementation during the pandemic, and qualitative analyses of patient experiences. Major awards: Sydney School of Health Sciences Teaching Citation (2022), Ashurst Prize for Outstanding Oral Presentation (2015), Helga Pettitt FHS Postgraduate Study Award (2010). Marita supervises Honours, Masters, and PhD students, including Mitchell Taylor on airway clearance in bronchiectasis. Her teaching spans undergraduate and postgraduate programs in cardiopulmonary and musculoskeletal physiotherapy. She collaborates on projects like the Lung Support Service, a nationwide text message program for chronic respiratory patients during the pandemic, and contributed to the commercialization of the Perx-R app for pulmonary rehab. Labs/teams: Active member of the Charles Perkins Centre, focusing on interdisciplinary chronic disease research and healthcare innovation.
Anna Salvati is an Associate Professor specializing in nanomedicine and drug delivery systems. Her research focuses on nanoparticle-cell interactions, biomolecular corona formation, and the physicochemical properties governing nanomaterial behavior in biological environments. Key research themes include cellular uptake mechanisms, toxicity of nanomaterials, and nanoparticle targeting strategies. Recent publications highlight her work on nanoparticle stability, membrane interactions, and environmental impacts of microplastics. Her studies integrate multiomics approaches, advanced imaging, and interlaboratory validation to address challenges in nanomedicine design and safety testing. Current projects explore the role of high-density lipoproteins in nanoparticle functionality and the modulation of drug release kinetics through material engineering.
